Condition 1: Stomach adenocarcinoma. Condition 2: stomach. Stomach, unspecified Body of stomach
Conditions
Interventions
Intervention 1: Choice in the first two platinum drugs, without supplements for 3 courses (each course is three weeks) starts. After this period, consistent with the pursuit of health again forced th
Treatment - Drugs
Choice in the first two platinum drugs, without supplements for 3 courses (each course is three weeks) starts. After this period, consistent with the pursuit of health again forced these people to co
In other group therapy with platinum Tablet Natural Factors Ultimate-Omega Factors 1200 mg of supplemental omega-3 fatty acids, Omega 6 and Omega-9 formula: Fish Oil Blend 400 mg, Flexseed Oil 400 mg,
Sponsors
Liver ans Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with gastric adenocarcinoma who that the chemotherapy will be. Exclusion criteria: People who are not taking medication due to cardiac obstruction; Pyloric obstruction due to people who are not able to take medicine; Diabetic patients; Patients with renal failure; Three months before entering the study, patients who are taking omega supplements.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Apoptosis. Timepoint: When you visit your doctor gastroenterologist positive patients with gastric cancer, gastric biopsy specimens obtained from the patient will be measured factors considered. This condition is almost three months, then three courses of chemotherapy and after chemotherapy, these patients re-biopsy specimens obtained from these samples will be measured rate of apoptosis activation. Method of measurement: Detect of Proteins and Gen Experision of Enzymes and Proteins Involved of Apoptosis Prosess. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of Chemoresistance. Timepoint: Three months after starting chemotherapy patient identification. Method of measurement: Detection of Proteins and Gen Expeition of Enzymes and Proteins Involved of Apoptosis Prosess. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHomayun Dolatkhah
Dept. of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University o
Outcome results
None listed